SNX12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.309800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.271400E-01
Normal-vs-Stage2
3.955600E-01
Normal-vs-Stage3
9.784400E-01
Normal-vs-Stage4
3.430400E-01
Stage1-vs-Stage2
8.768800E-01
Stage1-vs-Stage3
3.126200E-01
Stage1-vs-Stage4
5.468600E-01
Stage2-vs-Stage3
3.099600E-01
Stage2-vs-Stage4
4.951000E-01
Stage3-vs-Stage4
2.880600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.493400E-01
Normal-vs-AfricanAmerican
2.104000E-01
Normal-vs-Asian
8.271400E-01
Caucasian-vs-AfricanAmerican
1.661620E-01
Caucasian-vs-Asian
3.786400E-01
AfricanAmerican-vs-Asian
1.598770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.781200E-01
Normal-vs-Female
3.855600E-01
Male-vs-Female
8.788400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.849400E-01
Normal-vs-Age(41-60Yrs)
1.465800E-01
Normal-vs-Age(61-80Yrs)
6.340000E-01
Normal-vs-Age(81-100Yrs)
6.557200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.238200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.413200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.922200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.819600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.597900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.239400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.291600E-01
Normal-vs-Daily Drinker
7.177000E-01
Normal-vs-Weekly Drinker
5.546200E-01
Normal-vs-Occasional Drinker
1.824360E-01
Normal-vs-Social Drinker
3.894800E-01
Non Drinker-vs-Daily Drinker
6.830200E-01
Non Drinker-vs-Weekly Drinker
9.981000E-01
Non Drinker-vs-Occasional Drinker
8.198400E-02
Non Drinker-vs-Social Drinker
7.080600E-01
Daily Drinker-vs-Weekly Drinker
7.459200E-01
Daily Drinker-vs-Occasional Drinker
6.826000E-02
Daily Drinker-vs-Social Drinker
5.050200E-01
Weekly Drinker-vs-Occasional Drinker
1.538250E-01
Weekly Drinker-vs-Social Drinker
7.445000E-01
Occasional Drinker-vs-Social Drinker
2.252200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.042200E-01
Normal-vs-Grade 2
8.573800E-02
Normal-vs-Grade 3
6.199900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.787530E-02
Grade 1-vs-Grade 3
5.902600E-03
Grade 1-vs-Grade 4
4.042200E-01
Grade 2-vs-Grade 3
2.993400E-01
Grade 2-vs-Grade 4
8.573800E-02
Grade 3-vs-Grade 4
6.199900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.273800E-01
Normal-vs-NonDiabetic
3.956400E-01
Diabetic-vs-NonDiabetic
3.577800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.143400E-01
Normal-vs-NoPancreatitis
4.492400E-01
Pancreatitis-vs-NoPancreatitis
3.443600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.433400E-01
Normal-vs-N1
3.854200E-01
N0-vs-N1
2.746400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.336600E-01
Normal-vs-TP53-NonMutant
6.713400E-01
TP53-Mutant-vs-TP53-NonMutant
6.683000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
